| 000 | 01402 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515063120.0 | ||
| 264 | 0 | _c20071011 | |
| 008 | 200710s 0 0 spa d | ||
| 022 | _a0025-7680 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTau, Cristina | |
| 245 | 0 | 0 |
_a[Severe osteoporosis with vertebral crushes in juvenile dermatomyositis. Effect of oral alendronate therapy]. _h[electronic resource] |
| 260 |
_bMedicina _c2007 |
||
| 300 |
_a53-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadverse effects |
| 650 | 0 | 4 |
_aAlendronate _xtherapeutic use |
| 650 | 0 | 4 |
_aBody Height _xdrug effects |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCalcium, Dietary _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDermatomyositis _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSpinal Fractures _xchemically induced |
| 650 | 0 | 4 |
_aVitamin D _xtherapeutic use |
| 700 | 1 | _aRusso, Ricardo | |
| 773 | 0 |
_tMedicina _gvol. 67 _gno. 1 _gp. 53-6 |
|
| 999 |
_c16960154 _d16960154 |
||